The rising demand reported in the therapeutics segment is prognosticated to catapult it to the fore of the global antithrombin market in terms of application, finds Fortune Business Insights in a new study. The study is titled “Antithrombin Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2026.” According to the study, the global antithrombin market will exhibit a steady CAGR of 4.1% to reach a value of US$ 725.2 Mn by 2026 from US$ 490.4 Mn in 2018.
Browse Complete Report Details
Increasing Prevalence of Hereditary Antithrombin Deficiency to Boost Market
However, the high treatment cost of antithrombin may compel end users to look for cheaper alternatives or supplements. This may hamper the market globally. Again, developing countries in Asia Pacific may directly opt out of adopting antithrombin treatment because of the high price of this treatment. This may pose a challenge for market players, also hampering the overall profit percentage of the market.
Request Sample PDF
- Diagnostics & Others
- Goat Milk (Recombinant)
By Dosage Form
Table of content:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
- Executive Summary
- Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
- Key Insights
4.1 Porter’s five forces analysis
4.2 Reimbursement Scenario for Key Countries
4.3 Recent Industry Developments-Partnerships, Mergers, and Acquisitions
4.4 Technological Advancements in Anti-Thrombin Market
- Global Anti-Thrombin Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Application
5.2.3 Diagnostics & Others
5.3. Market Analysis, Insights and Forecast – By Source
5.3.2 Goat Milk
5.4 Market Analysis, Insights and Forecast – By Dosage Form
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1 North America
5.5.3 Asia Pacific
5.5.4 Rest of the World
Strong Distribution Network Enables SCL Behring, Grifols, and Shire Expand Global Footprint
The global antithrombin market was dominated by three major companies namely SCL Behring, Grifols, and Shire. In 2018, these three companies together accounted for the highest market share among others. They offer the most commonly used human antithrombin based anticoagulants. Besides this, they have a strong distribution network that makes them have the lion’s share.
Request Customization of this [email protected]
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]